Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Loading OPHT News...
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 0.32% | 73.35 | 0.9% | $628.11m | |
| CELG | Celgene Corporation | -0.08% | 131.26 | 1.1% | $437.57m | |
| AMGN | Amgen Inc. | 0.79% | 171.39 | 1.1% | $428.25m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.88% | 151.37 | 1.9% | $388.67m | |
| BIIB | Biogen Inc. | 2.14% | 294.08 | 1.2% | $369.29m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.85% | 468.54 | 2.7% | $323.23m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.99% | 136.55 | 1.9% | $224.00m | |
| ILMN | Illumina, Inc. | 0.12% | 194.15 | 3.5% | $222.63m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.96% | 37.43 | 19.8% | $145.52m | |
| INCY | Incyte Corporation | -1.61% | 124.34 | 2.6% | $135.50m | |
| CLVS | Clovis Oncology, Inc. | -0.15% | 71.77 | 18.0% | $123.60m | |
| KITE | Kite Pharma, Inc. | 1.02% | 128.09 | 16.1% | $116.66m | |
| TSRO | TESARO, Inc. | -0.89% | 112.99 | 14.7% | $114.54m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.01% | 83.07 | 4.4% | $113.75m | |
| A | Agilent Technologies, Inc. | 4.67% | 62.15 | 1.5% | $112.87m |
Company Profile
Ophthotech Corp. operates as a biopharmaceutical company. It focuses on discovering, developing and commercializing novel therapeutics to treat diseases of the back of the eye. It develops therapies for age-related macular degeneration. Its product candidates include Fovista Anti platelet derived growth factor Therapy, Zimura Anti-Complement and Aptamer Technology. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in New York, NY.